Kevin Pugh, MD
Orthopaedic Surgery · Pikeville, KYNPI 1477596302
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.7%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 61.3% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2024 at $19,299 and has fallen 52.3% since, to $9,207 in 2025. Among orthopaedic surgery clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $530.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$44K
- Smith+Nephew$15K
- UOC USA Inc$9K
- Zimmer Biomet$3K
- Heraeus Medical, LLC.$310
- Johnson & Johnson$128
- plus $1K from 34 others
What the payments were for
- Royalty or licence$27,38438%
- Consulting fees$37,76853%
- Speaking & faculty fees$2,0003%
- Travel & lodging$1,3742%
- Food & beverage$3,0324%
- Education$280%
- Other$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 24 | $43,874 |
| Smith+Nephew | 32 | $14,832 |
| UOC USA Inc | 8 | $8,623 |
| Zimmer Biomet | 13 | $2,630 |
| Heraeus Medical, LLC. | 3 | $310 |
| Johnson & Johnson(2 entities) | 2 | $128 |
| Integra Lifesciences Corporation | 5 | $113 |
| Stryker | 2 | $98 |
| Covidien LP | 2 | $91 |
| Medtronic | 4 | $90 |
| Linvatec Corporation | 1 | $68 |
| Avanos Medical | 3 | $67 |
| Heron Therapeutics, Inc. | 3 | $60 |
| AstraZeneca(2 entities) | 3 | $59 |
| Onkos Surgical, Inc. | 1 | $40 |
| Conmed Corporation | 1 | $39 |
| Checkpoint Surgical, Inc | 1 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Pacira Therapeutics, Inc. | 2 | $29 |
| Convatec Inc. | 2 | $29 |
| Polynovo North America LLC | 2 | $28 |
| Kerecis Limited | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Amgen | 1 | $21 |
| Eagle Pharmaceuticals, Inc. | 1 | $20 |
| Blue Surgical LLC | 1 | $19 |
| AbbVie | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| Davol Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Orthogenrx Inc. | 1 | $17 |
| Acacia Pharma Inc | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Pfizer | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$124,159
- Journey II$13,025
- Medial Pivot$5,483
- LEGION TKS$4,520
- Journey II BCS$3,260
- Legion$3,255
- Walter$2,125
- U2 Press-fit$2,040
- Journey II CR$1,260
- UMS U3$893
- REDAPT Revision Hip System$400
- PALACOS$213
- TFN-Advance$109
- ROSA$105
How this compares
$71,606 in reported general payments places this provider in the 90th percentile of 322 orthopaedic surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 295 | $106,486 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 476 | $3,296 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 21 | $3,054 |
| Cephalexin | 349 | $2,164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $639 |
| Doxycycline Monohydrate | 11 | $212 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $160 |
| Amoxicillin | 107 | $90 |
| Clindamycin Hcl | 20 | $70 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $65 |
| Levofloxacin | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $128 | $106,486295 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 322 orthopaedic surgery providers in Kentucky.
Other orthopaedic surgery in Pikeville
- Keith HallPikeville$30K
- Arthur MalkaniLouisville$9.6M
- Jonathan YerasimidesLouisville$4.3M
- John LewisLouisville$1.5M
- Akbar NawabLouisville$1M
- Samer HasanCrestview Hills$976K
- Phillip SingerBowling Green$816K
- Brent MorrisLexington$815K
- Joseph GreeneLouisville$581K
- Raymond GreiweFlorence$546K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.